The enzyme cyclooxygenase (COX), also referred to as prostaglandin-endoperoxide synthase (PTGS), is in charge of producing the vital biological mediators known as prostanoids, such as prostaglandins, prostacyclin, and thromboxane. Pain and inflammation symptoms can be reduced by pharmacologically inhibiting COX. The general public has had access to cyclooxygenase activity-inhibiting medications for about 100 years, including aspirin. The two cyclooxygenase isoforms, COX-1 and COX-2, have been identified. The COX-1 enzyme is frequently produced constitutively (i.e., in the gastric mucosa), whereas the COX-2 enzyme is induced (i.e., at sites of inflammation). Aspirin and ibuprofen are examples of NSAIDs that work by inhibiting COX to produce their desired effects. The non-steroidal anti-inflammatory drugs (NSAIDs) are the primary COX inhibitors.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V77404 | (+/-)-Catechin Gallate-13C3 (Catechin Gallate 13C3) | (+/-)-Catechin Gallate-13C3 is a 13C (carbon 13)-labeled (-)-Catechin gallate. | ||
V10613 | Esflurbiprofen | 51543-39-6 | Esflurbiprofen (BTS-24332; TT 063; BTS24332;TT063; SFPP;BTS 24332; TT-063; Trade name: Loqoa), the S-enantiomrer or S-isomer of Flurbiprofen, is a potent cyclooxygenase (COX) inhibitor and anonsteroidal anti-inflammatory drugs (NSAIDs) with antipyretic and analgesic activity. | |
V12164 | Nitroaspirin | 175033-36-0 | Nitroaspirin (NOASA;NCX4016; mNOASA) is a novel and potent nitric oxide (NO) donor with anticancer, antithrombotic and anti-platelet activities. | |
V77593 | 2-O-Sinapoyl makisterone A | 2-O-Sinapoyl makisterone A (compound 2) is a sinapic acid-ecdysterone hybrid and is a selective inhibitor of COX-2. | ||
V78015 | Anti-inflammatory agent 52 | Anti-inflammatory agent 52 (compound 7j) is an orally bioavailable, potent and specific COX-2 inhibitor. | ||
V78016 | Anti-inflammatory agent 53 | Anti-inflammatory agent 53 (compound 7c) is an orally bioavailable, potent and specific COX-2 inhibitor. | ||
V2894 | ATB-346 | 1226895-20-0 | ATB-346, a structural analog of naproxen (one of the NSAIDs-Nonsteroidal anti-inflammatory drugs), is anti-inflammatory agent. | |
V2102 | CAY10404 | 340267-36-9 | CAY10404 is novel, and highly selective inhibitor of COX-2 which has been reported to date, with a selectivity index (SI; SI = IC50COX-1/IC50COX-2) of >500,000. | |
V78861 | COX-1/2-IN-4 | COX-1/2-IN-4 is a COX inhibitor (antagonist) with IC50s of 0.239 μM and 0.191 μM for COX-1 enzyme and COX-2 enzyme, respectively. | ||
V79761 | COX-1/2-IN-5 | COX-1/2-IN-5 (compound 2a) is a dual (bifunctional) inhibitor of COX1/2 (IC50=2.650 μM, 0.958 μM) with anti-cancer activity. | ||
V80073 | COX-2-IN-31 | COX-2-IN-31 (compound 7b) is an orally bioactive COX/5-LOX dual (bifunctional) inhibitor (antagonist) with IC50 of 60 nM (COX-2) and 0.9 μM (5-LOX). | ||
V78864 | COX-2-IN-33 | COX-2-IN-33 (compound 5f) is a COX-2 inhibitor (IC50=45.5 nM) and a potential anti-inflammatory agent. | ||
V79472 | COX-2-IN-35 | COX-2-IN-35 (compound 7) is a selective COX-2 inhibitor (antagonist) with IC50 of 4.37 nM. | ||
V78603 | COX-2/15-LOX-IN-2 | COX-2/15-LOX-IN-2 is a potent dual COX-2 and 15-LOX inhibitor (antagonist) with IC50s of 0.065 μM and 1.86 μM, respectively. | ||
V78897 | COX-2/15-LOX-IN-3 | COX-2/15-LOX-IN-3 (compound 5k) is a dual (bifunctional) inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM respectively. | ||
V79276 | COX-2/15-LOX-IN-4 | COX-2/15-LOX-IN-4 (compound 5i) is a dual (bifunctional) inhibitor of COX-2/15-LOX with IC50s of 0.075 μM and 1.97 μM, respectively. | ||
V79114 | Diclofenac-13C6 sodium heminonahydrate (Diclofenac sodium 13C6 (1/2 water)) | Diclofenac-13C6 (sodium heminonahydrate) is a 13C (carbon 13)-labeled Diclofenac (Sodium). | ||
V21050 | FK3311 | 116686-15-8 | FK3311 is a cyclooxygenase-2 (COX-2) inhibitor. | |
V8326 | FR-122047 HCl | 130717-51-0 | FR-122047 HCl (FR 122047; FR122047), the hydrochloride salt of FR-122047, is a novel, potent and selective cyclooxygenase-1 (COX-1) inhibitor with potential anticancer activities. | |
V2703 | NS-398 | 123653-11-2 | NS-398 [also called NS 398,N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide]is a novel, highly potentandselective inhibitor of cyclooxygenase-2 (COX-2) that is used as a non-steroidal an-inflammatory agent with analgesic and antipyretic effects. |